The coenzyme specificity of enzymes is one of the critical parameters for the engineered production of biological compounds using bacteria. Since NADPH is produced abundantly in photosynthetic organisms, conversion of an NADH-specific enzyme into an NADPH-specific one is a useful approach for the efficient carbon-neutral production of biological compounds in photosynthetic organisms. In the present study, an NADH-specific ferredoxin reductase component, BphA4 of biphenyl dioxygenase BphA from Acidovorax sp. strain KKS102, was changed to an NADPH-dependent form using a method combining structure-based systematic mutations and site-directed random mutagenesis. The resultant CRG mutant, in which Glu 175 -Thr 176 -Gln 177 of an NADH-recognition loop in the wild-type BphA4 was replaced with Cys 175 -Arg 176 -Gly 177 , was highly specific and active for NADPH, and its biochemical and structural properties for NADPH were nearly the same as those of the wild-type BphA4 for NADH. In addition, this mutation project was assessed by a semiempirical prediction method of mutation effects, and the results suggested that the CRG mutant was one of the best NADPHspecific mutants.
INTRODUCTION
In the large-scale production of biological compounds using bacteria, redox balance is one of the critical conditions to be regulated; redox imbalance frequently causes the reduced production of biological compounds. The coenzyme specificity conversion of enzymes utilizing the pyridine nucleotides NADH and NADPH could therefore be an important approach to enhance the production of biological compounds. Accordingly, several groups have tried to convert the NADH/NADPH specificity of enzymes. One of the earliest reports of such a conversion appeared in 1990. Scrutton et al. [1] changed the coenzyme specificity of NADPH-dependent glutathione reductase by mutations of more than seven residues, which included substitutions of positively charged residues around the 2 -phosphate group of bound NADPH with negatively charged residues. However, the specificity conversion was not complete. A similar coenzyme specificity conversion was reported using NADP + -dependent ADH8 (alcohol dehydrogenase isozyme 8) [2] . In this case, substitutions of residues interacting with the 2 -hydroxy group and the pyrophosphate bridge converted the coenzyme specificity nearly completely. In addition to these examples, several reports showing coenzyme-specificity changes from NADPH to NADH have appeared.
Some groups have tried to change the coenzyme specificity of enzymes from NADH to NADPH. Although Marohnic et al. [3] succeeded in obtaining NADPH-specific microsomal cytochrome b 5 reductase by substituting Asp 239 , which interacts with the 2 -hydroxy group of NADH, with threonine, the specificity change of the mutant was not complete. Watanabe et al. [4] and Bocanegra et al. [5] succeeded in nearly completely changing the coenzyme specificity of NAD + -dependent xylitol dehydrogenases and the NAD + -dependent pyruvate dehydrogenase multienzyme complex respectively. In general, however, the specificity conversion from NADH into NADPH seems to be more difficult than that from NADPH into NADH, because it requires both the neutralization of negative charges on the 2 -phosphate group of NADPH and the formation of a space to accommodate the 2 -phosphate group. Indeed, examples of the coenzyme specificity conversion from NADH into NADPH have been described much less than those from NADPH into NADH.
In the large-scale production of biological compounds, NADH has been believed to be better than NADPH, because NADH is less expensive and more stable than NADPH. In addition, the NADH concentration in Escherichia coli cells in the growth phase (1.3 mM) is significantly higher than that of NADPH (0.39 mM) [6] , suggesting that NADH-dependent enzymes are preferable to NADPH-depending enzymes for large-scale production of metabolites. However, the NADH/NADPH ratio is different in other organisms, particularly photosynthetic organisms. Notably, the carbon neutrality of the large-scale production of biological compounds using photosynthetic organisms should be Abbreviations: 2YT-Amp medium, 1.6 % (w/v) tryptone/1 % (w/v) yeast extract/0.5 % NaCl containing 50 μg/ml ampicillin; WT, wild-type. 1 Correspondence may be addressed to either of these authors (email toshiya.senda@kek.jp or s-kimura@mx.ibaraki.ac.jp). The QTK and CTG mutants are involved in the specification of Japanese Published Unexamined Patent Applications JP 2011-10651 A. The structural co-ordinates reported for the ferredoxin reductase BphA4 mutants will appear in the PDB under codes 4H4P, 4H4Q, 4H4R, 4H4S, 4H4T, 4H4U, 4H4V, 4H4W, 4H4X, 4H4Y, 4H4Z and 4H50.
utilized widely [7] , because carbon-neutral applications could be leveraged to address global climate change concerns. It is therefore important to develop enzymes with NADPH specificity for the mass production of metabolites. Indeed, the production of butan-1-ol using cyanobacteria was significantly enhanced when an NADPH-dependent enzyme was used [8] .
In the present study, we tried to change the coenzyme specificity of an NADH-dependent ferredoxin reductase (BphA4) from Acidovorax sp. strain KKS102 and obtained NADPH-dependent ferredoxin reductases. BphA4 is an electron transfer component of the biphenyl dioxygenase BphA [9] [10] [11] , which is composed of the BphA1A2 complex, BphA3 (ferredoxin) and BphA4. BphA4 obtains two electrons from NADH and transfers each electron, one by one, to ferredoxin BphA3, which is a oneelectron carrier protein. BphA3 then shuttles the electron to the BphA1A2 complex to catalyse the hydroxylation of a biphenyl compound. Since electron transfer is a key process in redox reactions, conversion of the coenzyme specificity from NADH into NADPH would expand the possible usage of this system in photosynthetic organisms.
EXPERIMENTAL

Mutagenesis
Expression plasmids for mutant BphA4 genes were prepared from pKH204, which is a pUC119-derived high-level expression plasmid for WT (wild-type) BphA4 [12] . The prepared expression plasmids for BphA4 mutants were named with an amino acid sequence of residues 175-177 of the BphA4 mutant as pKA4-XXX, where XXX is the amino acid sequence of residues 175-177 represented by the one-letter code of amino acids. The resultant mutant protein was designated in the same manner. For example, pKA4-ATQ is an expression plasmid for a BphA4 mutant protein that has an amino acid sequence of Ala-Thr-Gln for residues 175-177. The resultant mutant protein is the ATQ mutant of BphA4.
The primers used for the preparation of BphA4 mutant genes are summarized in Supplementary Figure S1 (at http://www.biochemj.org/bj/462/bj4620257add.htm). The mutant genes were prepared using PCR with the KOD-plus DNA polymerase (Toyobo) as shown in Supplementary Figure S2 (at http://www.biochemj.org/bj/462/bj4620257add.htm). First, 5 -and 3 -side mutagenic fragments were amplified using pKH204 as a template DNA (first PCR). The two mutagenic fragments have overlap sequences as shown in Supplementary Figure S1 . The 5 -side mutagenic fragments containing mutations in the nucleotides encoding Glu 175 -Gln 177 were amplified using a forward primer, RV-M, and one of the mutagenic reverse primers MR-1-MR-27. The 3 -side mutagenic fragments were amplified using one of the mutagenic forward primers MF-1-MF-4 and reverse primer M13-47. After the first PCR, the 5 -and 3 -side mutagenic fragments were mixed and re-amplified using primers RV-M and M13-47 (second PCR). In the second PCR, the 5 -side mutagenic fragments amplified with MR-1-MR-3, MR-4 and MR-5, MR-6-MR-14, and MR-15-MR-27 were mixed with the 3 -side mutagenic fragments amplified with MF-1, MF-2, MF-3 and MF-4 respectively. The resultant DNA fragments were ligated into pUC119 using HindIII and BamHI sites to construct the expression plasmids. E. coli JM109 cells were transformed with the expression plasmids. The nucleotide sequences of the manipulated sites in the expression plasmids were analysed with an ABI PRISM 310 Genetic Analyzer. The E. coli cells containing the plasmids pKA4-ATQ, -DTQ, -TTQ, -NTQ, -ATK, -DTK, -TTK, -NTK, -QTT, -QTS, -TTA and -CTG were identified by the nucleotide sequence analyses of the plasmids.
Biochemical screening of mutants from random mutagenesis of residues 175 and 177
After the random mutagenesis using mutagenic primer MR-14, single colonies of E. coli JM109 harbouring pKA4-XTX were isolated from an LB plate containing 50 μg/ml ampicillin. Each clone was cultured in 1 ml of 2YT-Amp medium [1.6 % (w/v) tryptone/1 % (w/v) yeast extract/0.5 % NaCl containing 50 μg/ml ampicillin] per well of a 96-deep well culture plate at 37
• C using an MBR-022UP maximizer (TAITEC). When the D 600 of the medium reached approximately 0.3, IPTG was added to a final concentration of 0.2 mM, and the E. coli cells were cultured for more than 16 h.
After the culture, the amounts of BphA4 mutant proteins accumulated in the E. coli cells were evaluated by SDS/PAGE with visual inspection after the proteins were stained on gels with Coomassie Brilliant Blue R-250. E. coli clones, which accumulated mutant proteins in similar quantity to that of the WT, were cultured in a deep-well plate as described above for the secondary screening. The cultured E. coli cells were precipitated in the well by centrifugation, and were lysed by adding 100 μl of CelLytic TM B detergent solution (Sigma-Aldrich). After centrifugation of the lysed cells, an apparent NADPH-dependent ferricyanide reduction rate of 10 μl of the soluble fraction (v app NADPH ) was measured at 25
• C in buffer A [800 μl of 100 mM potassium phosphate, pH 7.0, 1 mM EDTA and 2 % (w/v) glycerol] containing 1.0 mM NADPH and 1.5 mM potassium ferricyanide using a Hitachi U-2010 spectrophotometer. An apparent NADH-dependent ferricyanide reduction rate of 10 μl of the soluble fraction (v app NADH ) was also measured at 25
• C in buffer A containing 1.0 mM NADH and 1.5 mM potassium ferricyanide. At this stage, clones showing v app NADPH values above 115 % of that of the E. coli JM109/pKA4-QTK were selected. Of the selected clones, clones with v app NADPH/NADH (= v app NADPH /v app NADH ) values above 1.0 were further selected, and their nucleotide sequences of the plasmids were analysed. The mutants obtained were overexpressed in large-scale culture and purified for further analysis.
Expression and purification of BphA4
E. coli JM109 cells transformed by an expression plasmid were cultured in 2YT-Amp medium at 37
• C. When the D 600 value reached approximately 0.3, IPTG was added to the medium with a final concentration of 0.2 mM. The cells were harvested after 16 h of induction.
Mutant BphA4 proteins were purified at 4 • C with a method similar to that used for the WT [13] . Harvested cells from a 2.1 litre culture medium were lysed on ice by sonication in 60 ml of 10 mM potassium phosphate (pH 7.0) containing 1 mM EDTA, 2 % (v/v) glycerol and 2 mM PMSF using a Branson model 450 sonifier (Emerson Japan). The lysate was then centrifuged at 18 000 g for 20 min. The supernatant was diluted approximately 4-fold with 10 mM potassium phosphate (pH 7.0) containing 1 mM EDTA (buffer B), and was applied to a Whatman DE52 (GE Healthcare) column (1.5 cm×15 cm) equilibrated with buffer B. After the column was washed with buffer B, the absorbed proteins were eluted with a linear gradient of potassium phosphate (pH 7.0) from 10 to 100 mM in 1.0 litre of buffer B. The fraction containing BphA4, which was identified using absorbance at 450 nm and SDS/PAGE, was collected. The collected fraction was dialysed against 3 litres of buffer B and applied to a Blue-Sepharose FF column (GE Healthcare) (3 cm×15 cm) equilibrated with buffer B. Absorbed proteins were eluted with buffer B containing 0.5 M NaCl after the column was washed with 50 ml of buffer B. Eluted fractions containing BphA4 were collected and concentrated to less than 5 ml with Amicon Ultra-15 (Millipore). The concentrated protein solution was desalted on a Sephadex G-25 (fine) (GE Healthcare) column (1.6 cm×30 cm) equilibrated with buffer A. Purified BphA4 was stored at − 25
• C. 
Transient kinetics
Rapid reactions were analysed by stopped-flow spectroscopy using a HI-TECK SF61DX2 stopped-flow system (TgK Scientific) in buffer A at 25
• C as described previously [14] . The reduction process of the FAD in BphA4 was measured by monitoring absorbance change at 450 nm. Equal volumes of the enzyme solution and the NAD(P)H solution were rapidly mixed. The initial concentrations of oxidized enzymes were 10 μM, and that of NAD(P)H was 0.5 mM. The apparent rate constants of reduction (k red ) of FAD by NAD(P)H were determined by twoexponential curve fitting.
Spectral changes of the WT and mutant BphA4 proteins during and after the electron transfer from NAD(P)H to ferricyanide were analysed as follows. Equal volumes of the enzyme solution containing potassium ferricyanide and the NAD(P)H solution were rapidly mixed, and the time course of the absorbance change at 450-700 nm was monitored. The initial concentrations of NAD(P)H, oxidized enzymes and potassium ferricyanide in the reaction mixture were 0.5 mM, 10 μM and 1.5 mM respectively. Under these experimental conditions, a turnover phase and a subsequent oxidation phase after the consumption of NAD(P)H were observed.
Crystal structure analysis of BphA4 mutants
BphA4 mutants were purified and crystallized as described previously [13] . Crystals of the reduced form (the NADP + complex) were prepared by the soaking method under anaerobic conditions [14, 15] . NADPH was dissolved (10 mM) in an artificial mother liquor (2.5 M sodium formate and 0.1 M acetate buffer, pH 5.4) [14] , and the BphA4 crystals were soaked in the solution at 20
• C for 2 h. The soaked crystals were then treated with cryoprotectant [2.5 M sodium formate, 0.1 M sodium acetate buffer and 27.5 % (v/v) glycerol, pH 5.4] and frozen with liquid nitrogen. Diffraction data were collected at 95 K with an ADSC CCD (charge-coupled-device) detector using a synchrotron radiation source at the Photon Factory in KEK. The diffraction data were processed and scaled using the XDS and XSCALE programs respectively [16] . The crystal structures of the BphA4 mutants were determined by the molecular replacement method with the AutoMR routine of Phenix and refined with the program Phenix.refine [17] .
Measurement of dissociation constants
Dissociation constants of the WT and mutant BphA4 proteins for NAD(P)
+ were determined by the titration method. BphA4 (19.5-20.5 mg/ml) in buffer C (100 mM Hepes/NaOH pH 7.0; the ionic strength of this buffer was adjusted to 0.15 M by adding NaCl) was titrated with NAD(P)
+ . The BphA4-NAD(P) + binding was monitored at 505 nm in the oxidized form.
Titration experiments of the reduced form of BphA4 were performed under anaerobic conditions [15] . Initially, BphA4 (19.5-20.5 mg/ml) in buffer C was reduced by adding nearly the equimolar amount of sodium dithionite. Reduction of BphA4 was confirmed by the spectrum of the protein. Then, the reduced BphA4 was titrated with NAD(P) + (74.7-90.
μM). The interaction between BphA4 and NAD(P)
+ was monitored with the absorbance at 750 nm, which is nearly the peak wavelength of a charge-transfer band between FAD and NAD(P)
+ . The dissociation constant (K d ) was obtained by the curve fitting using the equa-
, where A ∞ is the maximum absorbance difference, L t (ligand concentration) and A (absorbance difference) are the titration data, and P t is the total subunit concentration of BphA4. The least-squares fitting was performed using the GNUPLOT program (http://www.gnuplot.info/).
Measurement of the biological activity of BphA4 in E. coli
The electron transfer abilities of the WT and mutant BphA4 proteins in E. coli cells were confirmed by monitoring the decrease in biphenyls in the culture medium. For this purpose, plasmids pCA4123, pCA4123CRG and pCA123 were constructed. Plasmid pCA4123, a pCW ori + -derived plasmid, is an expression plasmid with two tandem tac promoters for the WT bphA4, bphA1, bphA2 and bphA3 genes. Plasmid pCA4123CRG was prepared from pCA4123 by substituting the WT bphA4 gene with the CRG mutant gene. Plasmid pCA123 is a control plasmid that contains only bphA1, bphA2 and bphA3 genes. E. coli JM109 cells were transformed with each plasmid and cultured at 37
• C in 2YT-Amp overnight. The E. coli cells were inoculated into Terrific Broth medium at the ratio of 1:100 (v/v) and cultured at 37
• C. When the D 600 reached approximately 0.5, the expression of the bphA genes was induced by 0.2 mM of IPTG and cultured for 24 h before harvesting. The harvested cells were washed twice using the M9 medium and resuspended in the M9 medium. The cell density was adjusted to D 600 = 0.5.
After pre-incubation for 15 min at 30
• C, 50 nmol of biphenyl was added to 0.5 ml of the M9 medium containing E. coli cells. The E. coli-containing medium was incubated at 30
• C, and the Residues 175, 176 and 177 (carbon atoms in cyan) are located close to the ribose moiety of bound NAD + . Carbon atoms of NAD + are shown in yellow. This Figure was prepared using the co-ordinates reported in [14] . Wat, water.
enzyme reaction was stopped by adding 3.5 μl of 3 M HCl. After 50 nmol of phenanthrene was added to the medium as an internal standard, the medium was then saturated with NaCl, and 1.2 ml of ethyl acetate was added. The medium was vortex-mixed for 2 min and centrifuged at 2000 g for 3 min. The supernatant (1 ml) was recovered, supplemented with sodium sulfate, vortex-mixed and centrifuged at 10 000 g for 2 min. Then, 0.8 ml of supernatant was dried by a centrifugal evaporator. The residual was dissolved with 0.1 ml of ethyl acetate. The resultant solution (1 μl) was analysed by the GC/MS model QP5050 (Shimadzu). The amount of biphenyl molecules was corrected using the total amount of phenanthrene.
RESULTS AND DISCUSSION
Selection of mutation residues
On the basis of the crystal structure of BphA4 in complex with were located close to the 2 -hydroxy group of NAD + ( Figure 1 ) [12, 14, 18] . These three consecutive residues, therefore, were selected as target residues for this mutation project. These residues were divided into two groups: the first one (group I) was composed of residues 175 and 177, and the second one (group II) of residue 176.
Systematic mutagenesis on residues 175 and 177 based on the crystal structure of the WT in complex with NADH Initially, residues in group I were systematically mutated based on the crystallographic results of the WT [12, 14] . In the WT, Glu 175 forms hydrogen bonds with the 2 -and 3 -hydroxy groups of the ribose moiety. To accommodate the 2 -phosphate group of NADPH, Glu 175 needs to be mutated into a smaller and/or hydrophilic residue. Therefore, five single mutants were prepared and purified: NTQ, DTQ, QTQ, TTQ and ATQ (see the Experimental section for the designation of the mutant proteins NADPH value of the QTK mutant needed to be approximately 10-fold higher.
The crystal structure of the QTK mutant was determined for further analysis (Supplementary Table S2 at http://www.biochemj. org/bj/462/bj4620257add.htm). A crystal of the QTK mutant was soaked in the artificial mother liquor containing NADPH under anaerobic conditions, and its crystal structure was determined. The obtained crystal structure showed no electron densities for NADP(H), suggesting that the QTK mutant cannot bind NADP(H) in a stable manner (Figure 2A ). This observation was consistent with the large K m NADPH value of this mutant (Supplementary Table  S1 ).
Random mutagenesis on residues 175 and 177
For a more intensive search of one or more target mutants, site-directed random mutagenesis on residues 175 and 177 was performed. Initially, E. coli clones harbouring mutant bphA4 genes were selected by the accumulation level of mutant proteins in E. coli cells. Of the 610 clones generated from the random mutagenesis, 205 clones showed levels of mutant BphA4 accumulation comparable with that of the WT. The selected clones were then subjected to an initial biochemical screening; clones were selected when the v app NADPH value was more than 115 % that of the QTK mutant, which is the best mutant obtained in the systematic mutagenesis at positions 175 and 177. This criterion selected seven out of 205 clones. The clones obtained were further screened by the apparent specificity for NADPH using v app NADPH/NADH . The CTG mutant showed the highest v app NADPH/NADH value (3.29) among the screened mutants (Supplementary Table  S3 at http://www.biochemj.org/bj/462/bj4620257add.htm). The steady-state kinetic study of the purified mutants showed that the CTG mutant was more NADPH-specific than the QTS and TTA Table S1 ). The CTG mutant has a comparable (k cat /K m )
NADPH value with that of the QTK mutant. However, the K m NADH value of the CTG mutant was substantially larger than that of the QTK mutant (Supplementary Table S1 ), suggesting that this mutant has a lower affinity for NADH than the QTK mutant. The hydrogen bonds between the 2 -and 3 -hydroxy groups of the ribose moiety of NADH and Glu 175 were lost by the replacement of Glu 175 with cysteine, resulting in the weak interaction with NADH.
Despite the low NADH affinity, no significant improvement was observed in the affinity to NADPH in the CTG mutant; the crystal structure of the CTG mutant showed no electron densities for NADPH in NADPH-soaked crystals, suggesting a low affinity for NADPH ( Figure 2B ). The low affinity for NADPH seems to cause a relatively slow reduction rate of FAD with NADPH (Supplementary Table S4 at http://www.biochemj.org/bj/462/bj4620257add.htm) compared with that of the WT with NADH. In the CTG mutant, the reduction rate of FAD with NADPH was comparable with that of NADH.
Mutations of Thr 176
To increase the affinity for NADPH, mutational effects on Thr 176 were systematically examined. The crystal structure of the WT-NAD + complex suggested that a negatively charged phosphate group, which is attached to the 2 -position of the ribose moiety of NADPH, is located close to residue 176 of the WT. Thr 176 was therefore substituted with neutral or positively charged residues (alanine, serine, valine, lysine or arginine) to avoid electrostatic repulsion with the negatively charged 2 -phosphate group of NADPH, resulting in the EAQ, ESQ, EVQ, EKQ and ERQ mutants respectively. Replacement of Thr 176 with bulky amino acids (leucine, isoleucine, methionine and aromatic residues) seemed not to be suitable for the mutation of Thr 176 , due to steric hindrance. To probe the effect of the negatively charged amino acid at residue 176, the T176D mutant (EDQ mutant) was also prepared.
Biochemical screening of the single mutants of Thr 176 revealed that the ERQ mutant showed the highest (k cat /K m ) NADPH and (k cat /K m ) NADPH/NADH values ( Figure 3 and Supplementary Table S1 ). Although the ERQ mutant still showed NADH preference, its K m NADPH value was much smaller than that of the WT, suggesting an improvement of affinity to NADPH (Supplementary Table  S1 ). The dissociation constant for NADPH in reduced form revealed that the replacement of Thr 176 with arginine seems to improve the affinity to NADPH (Supplementary Table S5 at http://www.biochemj.org/bj/462/bj4620257add.htm). Indeed, the crystallographic analysis of the ERQ mutant showed that a weak, but significant, electron density for bound NADP + was observed in the reduced form ( Figure 2C ). The interaction between the adenine ring of NADP + and the side chain of Arg 176 seems to contribute to stable binding with NADP + , suggesting that the substitution of Thr 176 with arginine is critical to increase the affinity to NADP(H).
Preparation of combined mutants
In 1990, simple additivity in transition-state binding interactions was found in mutations [19] , and some earlier mutagenesis projects have utilized simple additivity in an effective manner. Over 15 years later, Reetz and co-workers proposed rational methods for mutation projects; those methods seem to be based on the concept of simple additivity [20] [21] [22] . In the combinatorial active-site saturation test [20, 21] and iterative saturation mutagenesis [20, 22] , some mutations were combined to determine the best mutants in the sequence space. As shown in several examples, these methods have been considered effective and rational for obtaining good mutants that meet the criteria.
On the basis of these earlier examples, we combined two good mutants obtained in this study (CTG and ERQ mutants) to prepare the CRG mutant. As expected, the CRG mutant showed high specificity and activity for NADPH. First, the reduced CRG mutant formed a stable complex with NADP + in the crystal ( Figures 2D and 4) . Secondly, the dissociation constant for NADP + under the reduced conditions was improved approximately 37-fold in comparison with that of the WT (Supplementary Table S5 ). Furthermore, the catalytic activity and specificity for NADPH were also improved in the CRG mutant ( Figure 3) . The (k cat /K m ) NADPH/NADH value of this mutant increased to 3-fold that of the QTK mutant (Supplementary Table S1 ), and its FAD reduction rate with NADPH was comparable with that of the WT with NADH (Supplementary Table S4 ).
In the stopped-flow analysis of the CRG mutant using NADPH as an electron donor, the CRG mutant showed a typical absorption spectrum of the blue-semiquinone form of FAD at approximately 550-650 nm during the turnover phase. The spectral shape and changes during the turnover and the following oxidizing phases were similar to those observed in the WT with NADH [14] (Supplementary Figure  S3 at http://www.biochemj.org/bj/462/bj4620257add.htm). These spectra suggested that the rate-limiting step of the reaction cycle of the CRG mutant for NADPH and the WT for NADH were the oxidation step of the neutral blue-semiquinone form of FAD. In contrast, no obvious charge-transfer spectra were observed in the spectra of the CRG mutant for NADH, suggesting that the rate-limiting step of the CRG mutant for NADH was the binding process of NADH. These results showed that the pyridine nucleotide specificity of BphA4 was almost completely changed in the CRG mutant from the standpoint of the catalytic cycle.
Furthermore, crystallographic analyses revealed that the WT and the CRG mutant underwent essentially the same overall conformational changes upon reduction. Upon FAD reduction, the WT showed the rotation of the NADH-binding and C-terminal domains (residues 112-237 and residues 318-408 respectively) with respect to the FAD-binding domain (residues 1-111 and 238-317) [12, 14] . The two domains in the CRG mutant molecule also rotate by approximately 1.2
• upon FAD reduction, which is comparable with the rotation angle observed in the WT (1.5
• ) [14] . As a result, residues 368-373 significantly shifted in the CRG mutant, which seems to contribute to the formation of the high-affinity BphA3-binding site [14, 18] . These results suggested that the CRG mutant has a redox-dependent affinity regulation for BphA3 as observed in the WT (Supplementary Figure S4 at http://www.biochemj.org/bj/462/bj4620257add.htm).
The mechanism of co-factor specificity conversion observed in the CRG mutant was analysed on the basis of the crystal structure. This mutant reduces the affinity for NADH ( Figure 2D ). The reduction of the affinity for NADH can be explained by the E175C mutation. This replacement causes a lack of hydrogen bonds between Glu 175 and the 2 -and 3 -hydroxy groups of NAD + in the WT, leading to low affinity for NAD + . The increased affinity for NADPH was explained partly by the E175C and Q177G mutations. The crystal structure of the CRG mutant showed that Cys 175 and Gly 177 form a suitable pocket to accommodate the phosphorylated ribose moiety in NADP + . Furthermore, the stacking interaction between the adenine ring of NADP + and the guanidino group of Arg 176 seems to stabilize the binding of NADP(H) (Figure 4) .
Assessment of the CRG mutant
Although the cofactor specificity of the CRG mutant is converted almost completely from NADH into NADPH, we could not exclude the possibility that other BphA4 mutants have better activity with and specificity for NADPH than the CRG mutant, because our mutation search in the sequence space is rather limited; less than 10 % of the mutants in the sequence space were examined by the systematic and random mutations. We therefore assessed our mutation project by predicting the effects of mutations on the basis of simple additivity [19] . Briefly, Figure 5) . Accordingly, the mutational effects of all possible triple mutations that can be obtained by combining single mutations in residues 175, 176 and 177 were predicted using simple additivity ( Figure 6 ). The prediction suggested that QRG and ARG mutants exhibit comparable ( G ‡ )/RT values with that of the CRG mutant ( Figure 6B ). It is noteworthy that neither mutant was obtained in the random mutation of BphA4.
In biochemical analysis, the ARG mutant showed the highest ( G ‡ )/RT value as predicted from the simple additivity ( Figure 5B and Supplementary Table S1 ). In addition, crystallographic analysis of this mutant in the reduced form showed that NADP + stably binds to the mutant. Ala 175 and Gly 177 in the ARG mutant contribute to form a pocket accommodating the phosphorylated ribose moiety in NADP + ( Figure 2E ), as observed in the CRG mutant. These two residues seem to be critical to the high catalytic efficiency of the ARG mutant for NADPH. In addition, the Ala 175 in the ARG mutant is unlikely to form a hydrogen bond with NAD + . Accordingly, the ARG mutant has a low affinity for NADH, resulting in a high catalytic efficiency ratio (Supplementary Table S1 ).
Although the QRG mutant was predicted to have the highest G ‡NADPH /RT value ( Figures 5A and 6A Table S1 ), probably because the E175Q mutation contributes to a relatively high affinity for NADH. Crystallographic analyses showed that the Table  S1 , and G ‡NAD(P)H /RT (predicted) and ( G ‡ )/RT (predicted) are the predicted values calculated from the observed values of the single mutants in Supplementary Table S1 using the simple additivity of the mutation effects [19] .
QRG mutant could stably bind NADP
+ under reduced conditions ( Figure 2F ).
In vivo measurement of the BphA4 activity
The in vivo electron transfer activity of the CRG mutant was analysed in E. coli cells. The bphA4 gene encoding the WT or CRG mutant was co-expressed with bphA1, bphA2 and bphA3 genes in E. coli JM109 cells, and biphenyl hydroxylation activity was measured by GC/MS. The E. coli cells containing pCA123 showed minimal decreases in the biphenyl concentration. In contrast, the E. coli cells containing pCA4123CRG showed rapid decreases in the biphenyl concentration in the medium. The rate of decrease in the biphenyl concentration was comparable with that of E. coli containing pCA4123, which harbours all WT subunits of the biphenyl dioxygenase BphA. These results showed that the CRG mutant transferred an electron to BphA3 in the E. coli Table S1 at http://www.biochemj.org/bj/462/bj4620257add.htm). The predicted top 20 mutants are shown. The ARG and QRG mutants were prepared to assess the mutation project.
cells and that its in vivo apparent electron transfer activity was comparable with that of the WT BphA4 (Supplementary Figure  S5 at http://www.biochemj.org/bj/462/bj4620257add.htm). This result strongly suggested that the CRG mutant functioned normally with NADPH in E. coli cells as an electron transport component of the biphenyl dioxygenase BphA.
Conclusions
In the present study, we obtained a CRG mutant that almost completely converted the co-factor specificity from NADH into NADPH. This mutant was prepared by combining two mutants, each independently obtained from systematic and random mutagenesis. Our analyses revealed that the CRG mutant is functional both in vitro and in vivo, indicating that this mutant can be utilized in future applications for the carbonneutral production of biological compounds in photosynthetic organisms. The results of this mutation project were assessed using the simple additivity of the mutation effects, suggesting that the CRG mutant is one of the best of the possible mutants in this mutation project. Furthermore, the assessment proposed that the ARG and QRG mutants have high (k cat /K m ) NADPH and (k cat /K m ) NADPH/NADH values. The biochemical and crystallographic analyses showed that the ARG mutant was also one of the best mutants isolated in the present mutation project and that its cofactor specificity was converted almost as completely as found in the CRG mutant. These results showed that the prediction of the mutation effect based on simple additivity is useful for assessing the mutation project and can be utilized to identify good mutants. A mutation project with semi-empirical prediction of mutation effects therefore seems to lead to a novel approach to high-quality mutation projects.
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Figure S5 In vivo analysis of the BphA activity in E. coli
The biphenyl hydroxylation activity of E. coli transformed by pCA123, pCA4123 and pCA4123CRG were plotted with black (᭡), blue (᭹) and red () lines respectively. 
